Avalo Therapeutics, Inc.
$927.80M- Market cap
- $1.03B
- Debt
- +-$5.17M
- Cash
- −$98.34M
Capital structure 101% equity / -1% debt · EV / Revenue 15725.35x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AVTX · current priceP/S 17479.74x
$19.23Latest market snapshot
Implied fair value · at DPZ's multiple
$0.00100.0% below market
0.00 AVTX revenue / share×2.28x DPZ P/S=$0.00
Market $19.23Implied $0.00
DPZ · current priceP/S 2.28x
$341.08Latest market snapshot
Implied fair value · at AVTX's multiple
$2,610,196.02765,173.8% above market
149.33 DPZ revenue / share×17479.74x AVTX P/S=$2,610,196.02
Market $341.08Implied $2,610,196.02